Trans-arterial radioembolization for intermediate-advanced hepatocellular carcinoma: a budget impact analysis

BACKGROUND: Trans-arterial radio-embolization (TARE) is an emerging treatment for the management of hepatocellular carcinoma (HCC). TARE may compete with systemic chemotherapy, sorafenib, in intermediate stage patients with prior chemoembolization failure or advanced patients with tumoral macrovascu...

Descripción completa

Detalles Bibliográficos
Autores principales: Rognoni, Carla, Ciani, Oriana, Sommariva, Silvia, Bargellini, Irene, Bhoori, Sherrie, Cioni, Roberto, Facciorusso, Antonio, Golfieri, Rita, Gramenzi, Annagiulia, Mazzaferro, Vincenzo, Mosconi, Cristina, Ponziani, Francesca, Sacco, Rodolfo, Trevisani, Franco, Tarricone, Rosanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6034232/
https://www.ncbi.nlm.nih.gov/pubmed/29976149
http://dx.doi.org/10.1186/s12885-018-4636-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6034232/
https://www.ncbi.nlm.nih.gov/pubmed/29976149
http://dx.doi.org/10.1186/s12885-018-4636-7

Ejemplares similares